Kite Pharma CEO steps down from Teva board
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Arie Belldegrun resigned from the Teva Pharmaceutical Industries Ltd. board to focus on his responsibilities at Kite Pharma Inc.
Belldegrun is the chairman, president, CEO and founder of Kite Pharma. He joined the Teva board in 2013.
